STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results

25 Jul 2023 15:05:55 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

14 Jun 2023 06:30:35 By Nasdaq GlobeNewswire

Standard BioTools to Present at the Jefferies Healthcare Conference

25 May 2023 15:05:05 By Nasdaq GlobeNewswire

Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System

18 May 2023 06:30:13 By Nasdaq GlobeNewswire

Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

15 May 2023 06:30:14 By Nasdaq GlobeNewswire

Standard BioTools Reports First Quarter 2023 Financial Results

09 May 2023 15:05:02 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for First Quarter 2023 Financial Results

25 Apr 2023 15:30:00 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

20 Apr 2023 16:03:07 By Nasdaq GlobeNewswire

Standard BioTools introduces the Hyperion XTi Imaging System, breaks barriers to power significant advancement in spatial biology

17 Apr 2023 07:30:54 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

22 Mar 2023 07:30:45 By Nasdaq GlobeNewswire

Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors

15 Mar 2023 07:30:14 By Nasdaq GlobeNewswire

Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

14 Mar 2023 07:30:48 By Nasdaq GlobeNewswire

Standard BioTools to Present at 43rd Annual Cowen Health Care Conference

01 Mar 2023 15:05:45 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

21 Feb 2023 07:30:16 By Nasdaq GlobeNewswire

Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook

14 Feb 2023 15:05:03 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results

31 Jan 2023 07:30:53 By Nasdaq GlobeNewswire

Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

09 Jan 2023 07:30:02 By Nasdaq GlobeNewswire

Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer

03 Jan 2023 07:30:59 By Nasdaq GlobeNewswire

Standard BioTools Authorizes up to $20 Million of Share Repurchases

28 Nov 2022 07:30:00 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

22 Nov 2022 08:20:03 By Nasdaq GlobeNewswire